| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/26/2009 | WO2008152262A3 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 02/26/2009 | WO2008151440A4 Modifying glycoprotein production in plants |
| 02/26/2009 | WO2008151182A3 Herpes simplex virus amplicon vectors derived from primary isolates |
| 02/26/2009 | WO2008143892A9 Method of treating tuberculosis with interferons |
| 02/26/2009 | WO2007149852A3 Modified factor viii and factor ix genes and vectors for gene therapy |
| 02/26/2009 | WO2006084050A9 Libraries and methods for isolating antibodies |
| 02/26/2009 | WO2004096160A3 Vesicle-associated proteins |
| 02/26/2009 | US20090055967 Polynucleotides and polypeptides involved in post-transcriptional gene silencing |
| 02/26/2009 | US20090055942 Human Coagulation Factor VII Polypeptides |
| 02/26/2009 | US20090054624 useful in the treatment of a condition which is responsive to the PRO polypeptide, an agonist or antagonist thereof or an anti-PRO antibody |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054335 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells |
| 02/26/2009 | US20090054320 Vesiculins |
| 02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
| 02/26/2009 | US20090054252 Hemopexin-Like Structure as New Polypeptide-Scaffold |
| 02/26/2009 | US20090054241 Method for the Preparation of a Composition Based on 4-Hydroxyproline and the Uses Thereof in the Agronomical Field |
| 02/26/2009 | US20090053791 Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
| 02/26/2009 | US20090053769 Heterologous production of natural products in bacteria |
| 02/26/2009 | US20090053768 Novel Phospholipase C Enzyme (S) |
| 02/26/2009 | US20090053767 Method for producing human insulin-like growth factor i |
| 02/26/2009 | US20090053766 Methods and compositions for producing recombinant proteins using a gene for trna |
| 02/26/2009 | US20090053765 Variants of Beta-Glucosidase |
| 02/26/2009 | US20090053764 Salutaridinol 7-0-Acetyltransferase and Derivatives Thereof |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053762 Cell/tissue culturing device, system and method |
| 02/26/2009 | US20090053761 Polypeptide Mutagenesis Method |
| 02/26/2009 | US20090053760 Selective enzymatic amidation of c-terminal esters or acids of peptides |
| 02/26/2009 | US20090053735 Vector expressing n-deacetylase/n-sulfotransferase 2 |
| 02/26/2009 | US20090053700 Optical sorting method |
| 02/26/2009 | US20090053362 Novel upases and uses thereof |
| 02/26/2009 | US20090053311 Pharmaceutical Compositions for Treating or Preventing Bone Conditions |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053256 inducing an immune response to a poxvirus in a mammal by administering a composition comprising a nucleic acid molecule comprising nucleotide sequence encoding a variola F8 polypeptide, wherein nucleotide sequence is codon optimized for expression in both a mammalian cell and a bacterial cell |
| 02/26/2009 | US20090053241 inhibition of platelet derived growth factor receptor-beta (PDGFR beta ) on angiogenesis, and provides for treatment of angiogenesis; |
| 02/26/2009 | US20090053230 Anti-ox40l antibodies and methods using same |
| 02/26/2009 | US20090053227 Prostate Specific Genes and The Use Thereof in Design of Therapeutics |
| 02/26/2009 | US20090053223 Expression-enhanced polypeptides |
| 02/26/2009 | US20090053212 Humanized anti-human osteopontin antibody |
| 02/26/2009 | US20090053210 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 02/26/2009 | US20090053191 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 02/26/2009 | US20090053185 Coagulation factor x polypeptides with modified activation properties |
| 02/26/2009 | US20090053167 C-, S- and N-glycosylation of peptides |
| 02/26/2009 | US20090053147 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 02/26/2009 | CA2707840A1 Amino acid substituted molecules |
| 02/26/2009 | CA2696684A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | CA2696597A1 Foxm1 peptide and medicinal agent comprising the same |
| 02/26/2009 | CA2696027A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/25/2009 | EP2028493A1 Procalcitonin 3-116 |
| 02/25/2009 | EP2028275A2 Protein glycosylation modification in pichia pastoris |
| 02/25/2009 | EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/25/2009 | EP2028186A2 Hepatitis C inhibitor tri-peptides |
| 02/25/2009 | EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 02/25/2009 | EP2027280A1 Process for the preparation of polymyxin b employing ( paeni ) bacillus polymyxa |
| 02/25/2009 | EP2026837A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 02/25/2009 | EP2026825A2 Furanone-initiated polymers |
| 02/25/2009 | EP1883705A4 Multiplex method for increased proteomic coverage from histopathologically processed biological samples using liquid tissue preparations |
| 02/25/2009 | EP1551451B1 Use of escherichia coli heat labile toxin as an adjuvant in poultry |
| 02/25/2009 | EP1345495B1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1142996B1 Monoclonal antibody against apolipoprotein a-i |
| 02/25/2009 | EP1017721B1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/25/2009 | EP0896058B1 Novel semaphorin z and gene encoding the same |
| 02/25/2009 | EP0871763B1 Method for preparation of type ii collagen |
| 02/25/2009 | EP0852587B1 Synthetic peptides that inhibit il-6 activity |
| 02/25/2009 | EP0815141B2 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 02/25/2009 | CN101374955A Targeting vector-phospholipid conjugates |
| 02/25/2009 | CN101374948A Variant humicola grisea CBH1.1 |
| 02/25/2009 | CN101374852A Novel bacillus mHKcel cellulase |
| 02/25/2009 | CN101372705A Preparation of recombinant long-acting glucagon peptide analogue |
| 02/25/2009 | CN101372678A Keratin degrading bacteria NJY1 |
| 02/25/2009 | CN101372511A Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 02/25/2009 | CN101372502A Separating and extracting method of Bacillus subtilis lipopeptide antibiotic substance |
| 02/25/2009 | CN100464566C Method and equipment of changed digital color image |
| 02/25/2009 | CN100463970C Solid state fermentation process for producing product with rich probiotics polypeptide |
| 02/25/2009 | CN100463969C Process for preparing biological active peptide for improving lactic acid bacteria proliferation and fermentation to produce acid |
| 02/25/2009 | CN100463967C Testicular carnitine transfer protein and its gene |
| 02/25/2009 | CN100463962C Phenotypic screen of chimeric proteins |
| 02/25/2009 | CN100463922C Immunoassays for anti-HCV antibodies |
| 02/25/2009 | CN100463918C Novel epidermal growth factor protein and gene, and methods of use therefor |
| 02/24/2009 | US7495152 Identification and characterization of a novel alpha-amylase from maize endosperm |
| 02/24/2009 | US7495091 Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/24/2009 | US7495090 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein |
| 02/24/2009 | US7495088 Nuclease resistant nucleotide capable of hybridizing with complementary RNA in a manner which inhibits function of the RNA |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495085 Immunoglobulin for use in diagnosis, prevention and treatment of allergies, autoimmune, inflammatory and cell proliferative disorders |
| 02/24/2009 | US7495083 PRO940 antibodies |
| 02/24/2009 | US7495082 Antibodies to PRO4349 polypeptides |
| 02/24/2009 | US7495081 Framework patched anti-CD20 antibody |
| 02/24/2009 | US7495080 Cytokine receptor zcytor17 |
| 02/24/2009 | US7495079 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
| 02/24/2009 | US7495078 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
| 02/24/2009 | US7495077 Homogeneous preparations of IL-28 and IL-29 |
| 02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/24/2009 | US7494977 Polypeptides homologous to VEGF and BMP1 |
| 02/24/2009 | US7494804 Polynucleotide encoding cytokine receptor zcytor17 multimer |
| 02/24/2009 | US7494800 Which transfer N-acetylgalactosamine to N-acetylglucosamine via beta 1-4 linkage; host cells |
| 02/24/2009 | US7494799 Paramunity inducers based on attenuated rabbit myxoma virus |
| 02/24/2009 | US7494796 Site directed mutagenesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases; cells |
| 02/24/2009 | US7494793 21686, dehydrogenase |
| 02/24/2009 | US7494788 Entropic bristle domain sequences and their use in recombinant protein production |